In Sunday’s (April 7) Harness Racing Update, Harness Racing Medication Collaborative Chairman and Standardbred Owners of New York President Joe Faraldo’s Letter to the Editor in the publication’s Feedback section provides an informed analysis of the use of Lasix, the diuretic, race-day medication that is undergoing considerable scrutiny right now.
HRMC releases recommendations on clenbuterol and betamethasone
The Harness Racing Medication Committee released their recommendations on Wednesday (Dec. 5) for the two therapeutic medications, clenbuterol and betamethasone, that were distributed to 16 state racing commissions as well as the Association of Racing Commissioners International for their consideration in establishing medication rules.